Rating History for Actuate Therapeutics (ACTU) by B.Riley

More Stocks Rated by B.Riley | Latest Ratings for ACTU
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/15/2026 Mayank Mamtani Maintain Buy
(N/A)		 8.00
(20.00)		  
 		   Details